Trials / Completed
CompletedNCT05910086
Multimodal Approach to the Intrathecal Catheter for Obstetric Accidental Dural Puncture
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Accidental dural puncture is an uncommon complication of epidural analgesia and can cause postdural puncture headache.
Detailed description
The aim of this study the effectiveness of a protocol implemented in our department, according to the recommendations of good practice, on the reduction of the use of blood patchs in patients who have had an accidental dural puncture during the implementation of their spinal anesthesia, in order to prevent the use of the blood patch. In addition, intensity of headaches is evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | collection of data from the medical record | collection of data from the medical record: 1. During epidural space puncture = cerebrospinal fluid (CSF) reflux, presence of glucose / strip, saline injection, intrathecal catheter insertion, intrathecal levobupivacaine and sufentanil injection, catheter insertion time, number of punctures, function of the person performing the procedure. 2. Analgesia and hemodynamics during labor, blood pressure, pulse rate, amount of local anesthetic used, whether emergency cesarean section was performed 3. Demographic data (age, weight, height, body mass index (BMI)) 4. Post-partum monitoring of decubitus or orthostatic headaches, intensity, any other associated clinical signs 5. Analgesics used and their efficacy 6. The use of one or more blood patches, with the volume injected and their efficacy 7. Identification of the breach during epidural analgesia or after delivery 8. Call the patient at 1 week to reassess the episode and its consequences. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2023-06-18
- Last updated
- 2023-06-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05910086. Inclusion in this directory is not an endorsement.